Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Flurbiprofen Axetil for Prevention of Post-operative Sore Throat After Thyroidectomy
ChiCTR2100044271Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Mar 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and flurbiprofen axetil in Post-extubation sore throat (POST), dysphonia and postoperative nausea and vomiting (PONV) (4 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: post-operative sore throat and hoarseness. Started Mar 2021; status: recruiting.
02
Drugs
dexmedetomidineflurbiprofen axetil
03
Conditions
Post-extubation sore throat (POST)dysphoniapostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2100044271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044271.